Four-Year-Old Hospitalized With Severe Meningococcal Infection

A four-year-old boy from Holon is hospitalized at Wolfson Medical Center with a severe invasive meningococcal infection. The child arrived at the pediatric emergency room with rapidly developing symptoms and was diagnosed with the dangerous bacterial infection. His condition is currently stable.

Dr. Diana Tcher, head of pediatrics at Wolfson, described the infection as one of the most violent and rapidly progressing known in pediatric medicine, capable of causing systemic collapse and life-threatening conditions within hours. This case follows a similar incident in July, where a three-year-old boy died from a suspected meningococcal infection at Tel Aviv's Dana Children's Hospital despite resuscitation efforts.

The meningococcus bacterium, commonly found in the throat and nose without causing harm, can become aggressive in rare cases. It can enter the bloodstream, leading to severe illness, meningitis, and long-term complications. Early diagnosis and prompt antibiotic treatment are crucial for recovery.

Health authorities recommend vaccination against meningitis for all children up to age two, with later vaccinations also possible. The recommendation stems from awareness of the severe risks associated with meningococcus B, a rare but devastating illness that can cause death or lasting disabilities such as brain damage, paralysis, developmental delays, epilepsy, or deafness.

Although the Bexsero vaccine was not included in the national health basket this year, the Ministry of Health, in agreement with health maintenance organizations, has allocated NIS 17 million from its budget for a "support test" to fund vaccinations. This measure aims to inoculate children against meningococcus B due to concerns about a potential outbreak. Committee members noted the need for a dedicated budget for vaccinations in future health basket decisions.